http://rdf.ncbi.nlm.nih.gov/pubchem/patent/NZ-535850-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d173508996911b655b3513437237bbcf |
| filingDate | 2003-03-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_46b5e8adc5abea5d7e19e6976a34af48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0f9470117d4996f9ca7b2bfe6dc7cf31 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ace271075de46b72c157e9d4c48990e7 |
| publicationDate | 2008-08-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | NZ-535850-A |
| titleOfInvention | Novel therapeutic use of riboside of 5-aminoimidazole-4-carboxamide (acadesine) |
| abstract | Disclosed is the use of a compound of formula (I) wherein the substituents are as described in the specification or a pharmaceutically acceptable solvent or addition salt there of, for the preparation of a medicament for the treatment of a B-cell lymphoproliferative disorder in humans. In particular the compound of formula (I) can be acadesine. |
| priorityDate | 2002-03-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 45.